PRCTC: a machine learning model for prediction of response to corticosteroid therapy in COVID-19 patients
Open Access
- 12 January 2022
- journal article
- research article
- Published by Impact Journals, LLC in Aging
- Vol. 14 (1) , 54-72
Abstract
Corticosteroid has been proved to be one of the few effective treatments for COVID-19 patients. However, not all the patients were suitable for corticosteroid therapy. In this study, we aimed to propose a machine learning model to forecast the response to corticosteroid therapy in COVID-19 patients. We retrospectively collected the clinical data about 666 COVID-19 patients receiving corticosteroid therapy between January 27, 2020, and March 30, 2020, from two hospitals in China. The response to corticosteroid therapy was evaluated by hospitalization time, oxygen supply duration, and the outcomes of patients. Least Absolute Shrinkage and Selection Operator (LASSO) was applied for feature selection. Five prediction models were applied in the training cohort and assessed in an internal and an external validation dataset, respectively. Finally, two (C reactive protein, lymphocyte percent) of 36 candidate immune/inflammatory features were finally used for model development. All five models displayed promising predictive performance. Notably, the ensemble model, PRCTC (prediction of response to corticosteroid therapy in COVID-19 patients), derived from three prediction models including Gradient Boosted Decision Tree (GBDT), Neural Network (NN), and logistic regression (LR), achieved the best performance with an area under the curve (AUC) of 0.810 (95% confidence interval [CI] 0.760–0.861) in internal validation cohort and 0.845 (95% CI 0.779–0.911) in external validation cohort to predict patients’ response to corticosteroid therapy. In conclusion, PRCTC proposed with universality and scalability is hopeful to provide tangible and prompt clinical decision support in management of COVID-19 patients and potentially extends to other medication predictions.Keywords
This publication has 47 references indexed in Scilit:
- Sepsis and septic shockThe Lancet, 2018
- Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2018
- Adjunctive Glucocorticoid Therapy in Patients with Septic ShockNew England Journal of Medicine, 2018
- Lymphocyte count or percentage: which can better predict the prognosis of advanced cancer patients following palliative care?BMC Cancer, 2017
- Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysisIntensive Care Medicine, 2015
- MissForest—non-parametric missing value imputation for mixed-type dataBioinformatics, 2011
- Postoperative Lymphocyte Percentage Influences the Long-term Disease-free Survival Following a Resection for Colorectal CarcinomaJapanese Journal of Clinical Oncology, 2011
- Safety and Efficacy of Corticosteroids for the Treatment of Septic Shock: A Systematic Review and Meta‐AnalysisClinical Infectious Diseases, 2009
- Corticosteroids in the Treatment of Severe Sepsis and Septic Shock in AdultsJAMA, 2009
- C-Reactive Protein: An Activator of Innate Immunity and a Modulator of Adaptive ImmunityImmunologic Research, 2004